Ayana Pharma Ltd.,
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of Doxorubicin Hydrochloride Liposome Injection in Subjects With Ovarian Cancer. (NCT03681548) | Ayana Pharma Ltd., | 2018-08-29 |
Track Ayana Pharma Ltd., automatically
Every clearance here is in the API, with alerts when new ones post.